Lv3
270 积分 2020-12-24 加入
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
9小时前
待确认
Thalidomide can effectively prevent relapse in IgG4-related disease outweighing its side effects: a multicentre, randomised, double-blinded, placebo-controlled study
13小时前
已完结
Advances in the research of CXCL16 and psoriasis
7个月前
已完结
CXCL9, 10, 11/CXCR3 Axis Contributes to the Progress of Primary Sjogren’s Syndrome by Activating GRK2 to Promote T Lymphocyte Migration
7个月前
已完结
Role of the CXCR6/CXCL16 axis in autoimmune diseases
7个月前
已完结
In their own words: early childhood asthma and parents’ experiences of the diagnostic process
7个月前
已完结
[Recommendations for the diagnosis and treatment of Sjögren's syndrome in China]
7个月前
已完结
Efficacy and safety of telitacicept in patients with lupus nephritis: a single-center, real-world retrospective study
10个月前
已完结
Telitacicept: First Approval
10个月前
已完结
Recommendations for the diagnosis and management of lupus nephritis in China
10个月前
已完结
皖公网安备34019202002308
